Biotech | March 22, 2022
Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Data published in the prestigious journal ACS Central Science of the American Chemical Society
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
The company plans to launch the product immediately
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
Sputnik Light is the first component of Sputnik V
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Successful proposals will secure fully funded postdoctoral research positions
Subscribe To Our Newsletter & Stay Updated
